This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Human Genome Sciences, Inc.. Active years: 2012.
Company Filing History:
Years Active: 2012
Title: The Innovative Contributions of Jason B Bock
Introduction
Jason B Bock, a prominent inventor based in Potomac, MD, has made significant strides in the field of biotechnology. With a single patent to his name, Bock's innovative work revolves around albumin fusion proteins, demonstrating his expertise and commitment to advancing medical science.
Latest Patents
Bock's patent, titled "Albumin Fusion Proteins," encompasses a variety of novel elements related to albumin fusion proteins. The invention includes nucleic acid molecules that encode these proteins, as well as vectors containing these nucleic acids. It further describes host cells transformed with these nucleic acids and methods for producing and utilizing the albumin fusion proteins. The patent also covers pharmaceutical compositions comprising these proteins and outlines methods for treating, preventing, or ameliorating various diseases, disorders, or conditions.
Career Highlights
Jason B Bock has established himself as a valuable member of the scientific community, currently working at Human Genome Sciences, Inc. His research and innovations have potentially opened new pathways in therapeutic applications, showcasing the power of biotechnology in medicine.
Collaborations
Throughout his career, Bock has collaborated with notable colleagues including Craig A Rosen and William A Haseltine. These partnerships reflect a commitment to multidisciplinary teamwork, which is essential for driving innovation and addressing complex medical challenges.
Conclusion
In conclusion, Jason B Bock is an inventor whose work in albumin fusion proteins holds promise for the future of therapeutic development. His contributions not only highlight his individual capabilities but also the collaborative efforts of skilled professionals within the biotechnology sector. As innovations like his continue to emerge, the potential for advancements in treating diseases and improving patient outcomes remains vast.